Lv3
370 积分 2024-12-19 加入
Lipoprotein(a) Levels, Risk of Cardiovascular Events and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial
1个月前
已完结
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention
2个月前
已完结
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement
2个月前
已完结
Remnant cholesterol level modified the effects of intensive systolic blood pressure lowering treatment in high-risk hypertensive patients: a post hoc analysis of the ESPRIT trial
2个月前
已完结
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
2个月前
已完结
Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials
2个月前
已完结
Takayasu arteritis phenotypes and outcomes: A data-driven cluster analysis from a large international cohort
3个月前
已完结
MILK-BOTTLE PROBLEM
3个月前
已关闭
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement
3个月前
已完结
Spatial multi-omic map of human myocardial infarction
3个月前
已完结
皖公网安备34019202002308
